|Benefit-Cost Summary Statistics Per Participant|
|Taxpayers||$49||Benefits minus costs||($81)|
|Participants||$87||Benefit to cost ratio||$0.58|
|Others||$30||Chance the program will produce|
|Indirect||($53)||benefits greater than the costs||50 %|
|Net program cost||($194)|
|Benefits minus cost||($81)|
|Meta-Analysis of Program Effects|
|Outcomes measured||Treatment age||No. of effect sizes||Treatment N||Adjusted effect sizes(ES) and standard errors(SE) used in the benefit - cost analysis||Unadjusted effect size (random effects model)|
|First time ES is estimated||Second time ES is estimated|
Diastolic blood pressure^
The blood pressure in the arteries when the heart rests between beats. This is the second (or bottom) number in a blood pressure reading.
“Good cholesterol” that is associated with lower risk of cardiovascular disease.
“Bad cholesterol” that is associated with higher risk of cardiovascular disease.
Obese based on clinical guidelines for adults (body mass index of 30 or higher) or children (body mass index at or above the 95th percentile for children of the same age and sex), as appropriate.
Systolic blood pressure^
The blood pressure in the arteries when the heart beats. This is the first (or top) number in a blood pressure reading.
Loss or gain of total body weight
|Detailed Monetary Benefit Estimates Per Participant|
|Affected outcome:||Resulting benefits:1||Benefits accrue to:|
|Obesity||Labor market earnings associated with obesity||$33||$78||$0||$0||$112|
|Health care associated with obesity||$14||$7||$30||$7||$58|
|Mortality associated with obesity||$1||$2||$0||$36||$40|
|Program cost||Adjustment for deadweight cost of program||$0||$0||$0||($97)||($97)|
|Detailed Annual Cost Estimates Per Participant|
|Annual cost||Year dollars||Summary|
|Program costs||$182||2014||Present value of net program costs (in 2018 dollars)||($194)|
|Comparison costs||$0||2014||Cost range (+ or -)||25 %|
Benefits Minus Costs
Benefits by Perspective
Taxpayer Benefits by Source of Value
|Benefits Minus Costs Over Time (Cumulative Discounted Dollars)|
|The graph above illustrates the estimated cumulative net benefits per-participant for the first fifty years beyond the initial investment in the program. We present these cash flows in discounted dollars. If the dollars are negative (bars below $0 line), the cumulative benefits do not outweigh the cost of the program up to that point in time. The program breaks even when the dollars reach $0. At this point, the total benefits to participants, taxpayers, and others, are equal to the cost of the program. If the dollars are above $0, the benefits of the program exceed the initial investment.|
Cooper, Z., Doll, H.A., Hawker, D.M., Byrne, S., Bonner, G., Eeley, E., O’Connor, M.E., & Fairburn, C.G. (2010). Testing a new cognitive behavioural treatment for obesity: A randomized controlled trial with three-year follow-up. Behaviour Research and Therapy, 48(2010), 706-713
Davis, M.P., Rhode, P.C., Dutton, G.R., Redmann, S.M., Ryan, D.H., & Brantley, P J. (2006). A primary care weight management intervention for low-income African-American women. Obesity, 14(8), 1412-1420.
Hardcastle, S., Taylor, A., Bailey, M., & Castle, R. (2008). A randomised controlled trial on the effectiveness of a primary health care based counselling intervention on physical activity, diet and CHD risk factors. Patient Education and Counseling, 70(1), 31-39.
Jolly, K., Lewis, A., Beach, J., Denley, J., Adab, P., Deeks, J.J., Daley, A., & Aveyard, P. (2011). Comparison of range of commercial or primary care led weight reduction programmes with minimal intervention control for weight loss in obesity: Lighten Up randomised controlled trial. BMJ, 343.
Miller, E.R. ., Erlinger, T.P., Young, D.R., Jehn, M., Charleston, J., Rhodes, D., Wasan, S.K., & Appel, L.J. (2002). Results of the Diet, Exercise, and Weight Loss Intervention Trial (DEW-IT). Hypertension, 40(5), 612-618.
Nanchahal, K., Power, T., Holdsworth, E., Hession, M., Sorhaindo, A., Griffiths, U., Townsend, J., Thorogood, N., Haslam, D., Kessel, A., Ebrahim, S., Kenward, M., & Haines, A. (2012). A pragmatic randomised controlled trial in primary care of the Camden Weight Loss (CAMWEL) programme. BMJ, 2(3).
Sniehotta, F.F., Dombrowski, S.U., Avenell, A., Johnston, M., McDonald, S., Murchie, P., Ramsay, C.R., Robertson, K., & Araujo-Soares, V. (2011). Randomised controlled feasibility trial of an evidence-informed behavioural intervention for obese adults with additional risk factors. PloS One, 6(8).
ter Bogt, N.C., Bemelmans, W.J., Beltman, F.W., Broer, J., Smit, A.J., & van der Meer, K. (2009). Preventing weight gain: one-year results of a randomized lifestyle intervention. American Journal of Preventive Medicine, 37(4), 270-277.
Tsai, A.G., Wadden, T.A., Rogers, M.A., Day, S.C., Moore, R.H., & Islam, B.J. (2010). A primary care intervention for weight loss: results of a randomized controlled pilot study. Obesity, 18(8), 1614-1618.
Yardley, L., Ware, L.J., Smith, E.R., Williams, S., Bradbury, K.J., Arden-Close, E.J., Mullee, M.A., Moore, M.V., Peacock, J.L., Lean, M.E.J., Margetts, B.M., Byrne, C.D., Hobbs, R.F.D., & Little, P. (2014). Randomised controlled feasibility trial of a web-based weight management intervention with nurse support for obese patients in primary care. The International Journal of Behavioral Nutrition and Physical Activity, 11(67), 1-11.